Showing 761-770 of 6983 results for "".
Emrosi Launched in the US for Rosacea
https://practicaldermatology.com/series/dermwire-tv/emrosi-launched-in-the-us-for-rosacea/33943/In this week's DermwireTV, a new treatment for rosacea is launched in the US; long-term data is presented for tapinarof 1% cream for atopic dermatitis; and in our C-Suite Chats segment, we speak with the CEO and Co-Founder of Mama Sol.DermWireTV: AIRE SkinStore, Telehealth Cuts Consult Wait Times, Social Media and Realistic Expectations
https://practicaldermatology.com/topics/practice-management/dermwiretv-aire-skinstore-telehealth-cuts-consult-wait-times-social-media-and-realistic-expectations/19874/Launching with seven skincare brands, AIRE SkinStore allows dermatologists across the country to curate product recommendations, while providing discounts for their patients, says creator Dhaval Bhanusali, MD. Use of store-and-forward telemedicine can cut wait times for dermatology consults from 84Starting a Practice? Get Educated
https://practicaldermatology.com/topics/practice-management/starting-a-practice-get-educated/19109/You know your medicine, but how well do you know business topics, like human resources, accounting, marketing, staffing, and other aspects of running a practice? Consider hiring a consultant, says Todd Schlesinger, MD, FAAD.Tracking Expenses and Loss Prevention
https://practicaldermatology.com/topics/practice-management/tracking-expenses-and-loss-prevention/19495/How does chronic AD histopathology evolve from spongiosis-dominant lesions to lichenified, fibrotic plaques?
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/how-does-chronic-ad-histopathology-evolve-from-spongiosis-dominant-lesions-to-lichenified-fibrotic-plaques/48772/Christopher Bunick, MD, FAAD, discusses the roles of the six major cytokines that drive atopic dermatitis pathophysiology: IL-4, IL-13, IL-31, TSLP, IL-22, and IFN-γ.DWTV Extra: Phase 3 Data on Roflumilast for AD, PsO
https://practicaldermatology.com/programs/practical-dermatology/dwtv-extra-phase-3-data-on-roflumilast-for-ad-pso/35925/Study investigator Melinda Gooderham, MD, talks about the Phase 3 trials of roflumilast cream 0.15% for adults and children down to age 6 with atopic dermatitis and roflumilast foam 0.3% for patients older than 12 with psoriasis of the scalp and body.When Everyone Has “Skin in the Game”
https://practicaldermatology.com/issues/april-2025/when-everyone-has-skin-in-the-game/35622/In today’s dynamic medical and marketing world, partnerships with other practices, businesses, and organizations are ripe for the picking.Elucidating the Inflammatory Cascade May Help to Turn Out the Lights in Psoriasis
https://practicaldermatology.com/topics/psoriasis/elucidating-the-inflammatory-cascade-may-help-to-turn-out-the-lights-in-psoriasis/19943/Understanding the science behind psoriasis pathogenesis has raised the bar in the management of disease. Watch the video to visualize the patient journey, their unmet needs, and aim to set higher standards in the psoriasis landscape.Inside the Latest Edition, June 2021
https://practicaldermatology.com/topics/practice-management/inside-the-latest-edition-june-2021/19959/Go inside our issue on acne and rosacea to get tips on new acne treatments, management of maskne, and strategies to improve your bottom line!Keyword Selection, an Ekwa.com Educational Video
https://practicaldermatology.com/topics/practice-management/education-in-action/19282/